Zuranolone provides a rapid response without chronic dosing: Response to correspondence by ten Doesschate et al

被引：6

作者：

Arnaud, Alix ^{[1
]}

Bonthapally, Vijayveer ^{[1
]}

机构：

[1] Sage Therapeut Inc, 215 First St, Cambridge, MA 02142 USA

来源：

JOURNAL OF AFFECTIVE DISORDERS | 2022年 / 301卷

关键词：

Major depressive disorder; Zuranolone; Mental health; Neuroactive steroid; Depression; TRIAL;

D O I：

10.1016/j.jad.2022.01.059

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：445 / 447

页数：3

共 11 条

[1] Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator [J].

Althaus, Alison L. ;

Ackley, Michael A. ;

Belfort, Gabriel M. ;

Gee, Steven M. ;

Dai, Jing ;

Nguyen, David P. ;

Kazdoba, Tatiana M. ;

Modgil, Amit ;

Davies, Paul A. ;

Moss, Stephen J. ;

Salituro, Francesco G. ;

Hoffmann, Ethan ;

Hammond, Rebecca S. ;

Robichaud, Albert J. ;

Quirk, Michael C. ;

Doherty, James J. .

NEUROPHARMACOLOGY, 2020, 181

[2] Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder [J].

Arnaud, Alix ;

Suthoff, Ellison ;

Stenson, Katie ;

Werneburg, Brian ;

Hodgkins, Paul ;

Bonthapally, Vijayveer ;

Jonas, Jeffrey ;

Meyer, Kellie ;

O'Day, Ken .

JOURNAL OF AFFECTIVE DISORDERS, 2021, 285 :112-119

[3]

Clayton AH., 2023, J CLIN PSYCHIAT, V84, p22m14445, DOI [DOI 10.4088/JCP.22M14445, 10.4088/JCP.22m14445]

[4] Mental Health in COVID-19 Pandemic: A Meta-Review of Prevalence Meta-Analyses [J].

de Sousa, Geovan Menezes ;

Tavares, Vagner Deuel de Oliveira ;

de Meiroz Grilo, Maria Lara Porpino ;

Coelho, Monique Leite Galvao ;

de Lima-Araujo, Geissy Lainny ;

Schuch, Felipe Barreto ;

Galvao-Coelho, Nicole Leite .

FRONTIERS IN PSYCHOLOGY, 2021, 12

[5] The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018) [J].

Greenberg, Paul E. ;

Fournier, Andree-Anne ;

Sisitsky, Tammy ;

Simes, Mark ;

Berman, Richard ;

Koenigsberg, Sarah H. ;

Kessler, Ronald C. .

PHARMACOECONOMICS, 2021, 39 (06) :653-665

[6] Trial of SAGE-217 in Patients with Major Depressive Disorder [J].

Gunduz-Bruce, Handan ;

Silber, Christopher ;

Kaul, Inder ;

Rothschild, Anthony J. ;

Riesenberg, Robert ;

Sankoh, Abdul J. ;

Li, Haihong ;

Lasser, Robert ;

Zorumski, Charles F. ;

Rubinow, David R. ;

Paul, Steven M. ;

Jonas, Jeffrey ;

Doherty, James J. ;

Kanes, Stephen J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (10) :903-911

[7]

Habert Jeffrey, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.15r01926

[8]

Paykel E S, 2008, Dialogues Clin Neurosci, V10, P431

[9]

Pratt Laura A, 2017, NCHS Data Brief, P1

[10]

Rush Augustus John, 2021, Neuropsychiatr Dis Treat, V17, P2333, DOI 10.2147/NDT.S305331

← 1 2 →